HK innoen slightly increased its revenue in the second quarter of this year while significantly expanding its operating profit compared to the same period last year. However, both operating profit and net income declined compared to the immediately preceding quarter, resulting in a mixed profitability trend across quarters.

According to the second-quarter earnings disclosed by HK innoen on the 29th, revenue amounted to KRW 267.225 billion, up 1.6% from the same period last year. During the same period, operating profit was approximately KRW 30 billion, up 53.6%, and net income stood at KRW 13.674 billion, up 13.6%. The operating profit growth rate significantly outpaced the revenue growth rate, indicating improved profitability year over year.

On the other hand, profit figures declined when compared to the previous quarter. Second-quarter operating profit fell 9.6% from the prior quarter, while net income dropped 47.3%. In other words, revenue, operating profit, and net income all increased year over year, but both profit metrics declined on a quarter-over-quarter basis.

Going forward, the sales trends of key pharmaceuticals and the health and beauty business, cost management, and quarterly profitability changes are cited as key factors to watch.

[This article was written with AI assistance. This article is investment reference information based on publicly available market data and does not recommend buying or selling any specific stock. Investment decisions and any resulting responsibility lie solely with the investor.]